KINASE-INHIBITOREN

European patent · EP2710007 · In force

Register entry

Publication number
EP2710007
Application number
EP12785097
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 16, 2012
Published
Mar 26, 2014
Granted
Dec 11, 2019
Protection ends at the latest
May 15, 2032
Next annual fee due
May 31, 2027
IPC classes
C07D 487/04 (2006.01)
C07D 403/04 (2006.01)
C07D 401/04 (2006.01)
A61K 31/519 (2006.01)
A61P 29/00 (2006.01)
A61P 35/00 (2006.01)
Priority
US 201161487233 P 17.05.2011
PCT application
PCT/US2012/038214 16.05.2012
PCT publication
WO2012/158843 22.11.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2026

    Change

    Published in Swissreg on 01.06.2026

  2. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  3. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  4. Jun 9, 2023

    Change

    Published in Swissreg on 09.06.2023

  5. Apr 1, 2020

    Corrected

    Owner
    The Regents of the University of California, 1111 Franklin Street, 12th Floor, Oakland, CA 94607, USA, Principia Biopharma Inc., 220 East Grand Avenue, South San Francisco, CA 94080, USA → The Regents of the University of California, 1111 Franklin Street, 12th Floor, Oakland, CA 94607, USA, Principia Biopharma, Inc., 220 East Grand Avenue, South San Francisco, CA 94080, USA

    Published in Swissreg on 01.04.2020

  6. Mar 31, 2020

    Address changed

    Owner
    Principia Biopharma, Inc., 2500 Sand Hill Road, Suite 203, Menlo Park, California 94025, USA, The Regents of the University of California, 1111 Franklin Street, 12th Floor, Oakland, CA 94607, USA → The Regents of the University of California, 1111 Franklin Street, 12th Floor, Oakland, CA 94607, USA, Principia Biopharma Inc., 220 East Grand Avenue, South San Francisco, CA 94080, USA

    Published in Swissreg on 31.03.2020

  7. Mar 7, 2020

    Agent entered

    Representative
    TR-IP Consulting LLC, Route du Coutset 18, 1485 Nuvilly

    Published in Swissreg on 07.03.2020

  8. Dec 11, 2019

    Granted

    Published in Swissreg on 11.12.2019

Parties

Holder

The Regents of the University of California

1111 Franklin Street, 12th Floor, Oakland, CA 94607, US

Principia Biopharma Inc.

Principia Biopharma, Inc.

220 East Grand Avenue, South San Francisco, CA 94080, US

Agent

TR-IP Consulting Sàrl

TR-IP Consulting LLC

Route du Coutset 18, 1485 Nuvilly

In liquidation

Inventor

BRAMELD, Kenneth Albert

Menlo Park California 94027, US

MCFARLAND, Jesse

Oakland California 94606, US

CHOY, Jonathan

Lafayette California 94549, US

KRISHNAN, Shyam

San Francisco California 94131, US

TAUNTON, John William, Jr.

San Francisco California 94110, US

GOLDSTEIN, David Michael

Redwood City California 94061, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.